StonvexLoading…
StonvexStonvexStonvexCore line items from UBSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $311.96M | $330.96M | $263.25M | $276.63M |
Operating Income | $475.78M | $462.85M | $359.74M | $324.44M |
Net Income | $379.63M | $367.74M | $289.02M | $260.10M |
EPS (Diluted) | $2.80 | $2.83 | $2.40 | $2.55 |
Total Assets | $29.49B | $29.33B | $26.18B | $19.66B |
Total Liabilities | $24.97B | $24.61B | $21.89B | $16.30B |
Cash & Equivalents | $1.18B | $3.76B | $2.21B | $837.49M |
Free Cash Flow OCF − CapEx | $743.96M | $594.16M | $121.42M | $140.88M |
Shares Outstanding | 135.12M | 129.51M | 120.09M | 101.85M |